Physical training effects in renal transplant recipients

Clinical Transplantation

Volumn 24, Issue 4, 2010, Pages 510-514

  Romano, G ^a   Simonella, R ^b   Falleti, E ^a   Bortolotti, N ^a   Deiuri, E ^a   Antonutto, G ^a   De Vita, S ^a   Ferraccioli, G F ^c   Montanaro, D ^a  

^a Tissue Typing Laboratory   (Italy)

^b Rehabilitation Unit   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cardiovascular risk; Exercise; Quality of life; Renal transplantation; Working capacity

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; INTERLEUKIN 6; LACTIC ACID; LIPOPROTEIN A; MYOGLOBIN; PARATHYROID HORMONE; TROPONIN;

ADULT; AGED; ARTICLE; BODY FAT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART RATE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KINESIOTHERAPY; LACTATE BLOOD LEVEL; MALE; MUSCLE MASS; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; THERAPY EFFECT; TREATMENT DURATION; WORK CAPACITY;

ADULT; AGED; EXERCISE THERAPY; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955725348     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01098.x     Document Type: Article

References (46)

1. Clyne N. Physical working capacity in uremic patients. Scand J Urol Nephrol 1996, 30:247.
2. Painter P, Messer-Rehak D, Hanson P, Zimmerman SW, Glass NR. Exercise capacity in hemodialysis, CAPD, and renal transplant patients. Nephron 1986, 42:47.
3. Painter PL, Luetkemeier MJ, Dibble S. Health related fitness and quality of life in organ transplant recipients. Transplantation 1997, 64:1795.
4. Painter PL, Tomlanovich SL, Hector LA. A randomized trial of exercise training following renal transplantation. Transplantation 2002, 74:42.
5. Mann JFE. What are short-term and long-term consequences of anaemia in CRF patients? Nephrol Dial Transplant 1999, 14(Suppl. 2).
6. Mayer G, Thum J, Cada EM, Stummvoll HK, Graf H. Working capacity is increased following recombinant human erythropoietin treatment. Kidney Int 1988, 34:525.
7. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J 1990, 300:573.
8. Clyne N, Jogestrand T, Lins L-E, Pehrsson SK. Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity. Nephron 1994, 67:322.
9. Williams B, Hattersley J, Layward E, Walls J. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 1991, 40:779.
10. Clyne N, Esbjornson M, Jogestrand T, Lins L-E, Pehrsson SK. Effects of renal failure on skeletal muscle. Nephron 1993, 63:395.
11. Bradley JR, Anderson JR, Evans DB, Cowley AJ. Impaired nutritive skeletal muscle blood flow in patients with chronic renal failure. Clin Sci (Lond) 1990, 79:239.
12. Rogerson ME, Rylance PB, Wilson R. Carnitine and weakness in haemodialysis patients. Nephrol Dial Transplant 1989, 4:366.
13. Ahmad S, Robertson HT, Golper TA. Multicentre trial of L-carnitine in maintenance hemodialysis patients. Clinical and biochemical effects. Kidney Int 1990, 38:912.
14. Guarnieri G, Biolo G, Zanetti M, Barazzoni R. Chronic systemic inflammation in uremia: potential therapeutic approaches. Semin Nephrol 2004, 24:441.
15. Murtagh BM, Anderson HV. Inflammation and atherosclerosis in acute coronary syndromes. J Invasive Cardiol 2004, 16:377.
16. Danesh J, Wheeler JG, Hirschfield GM. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-97.
17. Jungers P, Massy ZA, Nguyen K. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997, 12:2597.
18. USRDS 1994 Annual Report. Am J Kidney Dis 1994, 24(Suppl. 2):S88.
19. Parfrey PS, Harnett JD. Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol Necker Hosp 1994, 23:311.
20. Stenvinkel P, Ketteler M, Johnson RJ. IL-10, IL-6, and TN-Alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005, 67:1216.
21. Maher BA, Lamping DL, Dickinson CA, Murawinski BJ, Olivier DC, Santiago GC. Psychosocial aspects of chronic hemodialysis: the national Cooperative Dialysis Study. Kidney Int 1983, 23(Suppl.):50.
22. Evans RW, Manninen DL, Garrison LP. The quality of life of patients with end-stage renal disease. N Engl J Med 1985, 312:553.
23. Levy N. The effects of psychosocial factors on the rehabilitation of the artificial man. Dial Transplant 1979, 8:213.
24. Mckee DC, Burnett GB, Raft DD, Batten PG, Bain KP. Longitudinal study of neuropsychological functioning in patients on chronic hemodialysis: a preliminary report. J Psychosom Res 1982, 26:511.
25. Ierodiakonou CH, Papadimitriou M, Papakosta-Varlami E, Vargemezis V, Metaxas P. Psychological problems of patients undergoing chronic dialysis: diagnosis and treatment. Mater Med Greca 1978, 6:55.
26. Iordanidis P, Karabina E, Mikos T, Ritsas I, Iacovides A, Ierodiakonou CH. The psychosocial problems of end-stage renal disease patients. Transplantation 1993, 3:45.
27. Pietrobelli A, Formica C, Wang Z, Heymsfield SB. Dual-energy X-ray absorptiometry body composition model: review of physical concepts. Am J Physiol Endocrinol Metab 1996, 271:E 941.
28. Wang W, Wang Z, Faith MS, Kotler D, Shih R, Heymsfield SB. Regional skeletal muscle measurement: evaluation of new dual-energy X-ray absorptiometry model. J Appl Physiol 1999, 87:1163.
29. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002, 76:378.
30. Zamparo P, Antonutto G, Capelli C, Di Prampero PE. Effects of different after-loads and knee angles on maximal explosive power of the lower limbs in humans. Eur J Appl Physiol 2000, 82:381.
31. Franz MJ, Vanwormer JJ, Crain AL. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007, 10:1755.
32. Horii Y, Iwano M, Hirata E. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 1993, 39(Suppl. 1).
33. Odum J, Peh CA, Clarkson AR. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994, 9:309.
34. Castaneda C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic Kidney disease. Am J Kidney Dis 2004, 43:607.
35. Korn T, Bettelli E, Oukka M, Kuckroo VK. IL17 and Th17 cells. Annu Rev Immunol 2009, 27:485.
36. Chevrel G, Page G, Granet C, Streichenberger N, Varennes A, Miossec P. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 2003, 137:125.
37. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32.
38. San Segundo D, López-Hoyos M, Fernández-Fresnedo G. T(H)17 versus Treg cells in renal transplant candidates: effect of a previous transplant. Transplant Proc 2008, 40:2885.
39. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L. Markers of inflammation before and after renal transplantation. Transplantation 2005, 80:47.
40. Budgett R, Newsholme E, Lehmann M. Redefining the overtraining syndrome as the unexplained underperformance syndrome. Br J Sports Med 2000, 34:67.
41. Robson PJ. Elucidating the unexplained underperformance syndrome in endurance athletes: the interleukin-6 hypothesis. Sports Med 2003, 30:771.
42. Pederson BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 2001, 7:18.
43. Nieman DC, Nehelsen-Cannarella SL, Fagoaga OR. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 1998, 30:671.
44. Ostrowski K, Rohde T, Asp S. Pro- and antiinflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999, 515(Pt. 1):287.
45. Ullum H, Haahr PM, Diamant M. Bicycle exercise enhances IL-6, but does not change IL-1 alpha, IL-beta, IL-6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol 1994, 77:93.
46. Baker DG, Ekhator NN, Kasckow JV. Plasma and cerebrospinal fluid interleukin-6 concentration in posttraumatic stress disorder. Neuroimmunomodulation 2001, 9:209.